Form 4 for CCCC C4 Therapeutics, Inc.
Accepted 2026-07-13 16:33:49 ET · period of report 2026-07-10 · accession 0001470831-26-000705 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-13 16:33 | 2026-07-10 | CCCC | REYNO LEONARD | Chief Medical Off | M - OptEx | $0.00 | +15.3K | 379.8K | +4% | $0 | |
| 2026-07-13 16:33 | 2026-07-10 | CCCC | REYNO LEONARD | Chief Medical Off | F - Tax | $4.06 | -7,397 | 372.4K | -2% | -$30.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-07-10 | M | A | 15,325 | $0.00 | 379,803 | D | — | — | (F1) Reflects the acquisition of shares of Common Stock upon vesting of previously disclosed grants of restricted stock units ("RSUs"). The grant of RSUs was initially reported in Table I of the Form 4 filed by the Reporting Person on July 12, 2023. |
| 2 | Common | Common Stock | 2026-07-10 | F | D | 7,397 | $4.06 | 372,406 | D | — | — | (F2) Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs and does not represent a sale by the Reporting Person. |